HomeCompareGIAC vs JNJ

GIAC vs JNJ: Dividend Comparison 2026

GIAC yields 19.55% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GIAC wins by $51.0K in total portfolio value
10 years
GIAC
GIAC
● Live price
19.55%
Share price
$10.23
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$71.0K
Annual income
$6,421.19
Full GIAC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GIAC vs JNJ

📍 GIAC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGIACJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GIAC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GIAC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GIAC
Annual income on $10K today (after 15% tax)
$1,661.76/yr
After 10yr DRIP, annual income (after tax)
$5,458.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, GIAC beats the other by $4,754.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GIAC + JNJ for your $10,000?

GIAC: 50%JNJ: 50%
100% JNJ50/50100% GIAC
Portfolio after 10yr
$45.5K
Annual income
$3,624.48/yr
Blended yield
7.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GIAC
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$13.00
+27.1% upside vs current
Range: $13.00 — $13.00
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GIAC buys
0
JNJ buys
0
No recent congressional trades found for GIAC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGIACJNJ
Forward yield19.55%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$71.0K$20.0K
Annual income after 10y$6,421.19$827.78
Total dividends collected$39.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$13.00$228.73

Year-by-year: GIAC vs JNJ ($10,000, DRIP)

YearGIAC PortfolioGIAC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,655$1,955.02$10,676$355.77+$2.0KGIAC
2$15,853$2,312.22$11,407$389.39+$4.4KGIAC
3$19,670$2,707.05$12,198$426.53+$7.5KGIAC
4$24,186$3,139.06$13,056$467.62+$11.1KGIAC
5$29,486$3,607.24$13,987$513.12+$15.5KGIAC
6$35,660$4,110.06$14,998$563.56+$20.7KGIAC
7$42,802$4,645.48$16,098$619.52+$26.7KGIAC
8$51,009$5,211.06$17,295$681.69+$33.7KGIAC
9$60,384$5,803.99$18,599$750.82+$41.8KGIAC
10$71,032$6,421.19$20,022$827.78+$51.0KGIAC

GIAC vs JNJ: Complete Analysis 2026

GIACStock

Gesher I Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Tel Aviv, Israel.

Full GIAC Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GIAC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GIAC vs SCHDGIAC vs JEPIGIAC vs OGIAC vs KOGIAC vs MAINGIAC vs ABBVGIAC vs MRKGIAC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.